AVITAC
Live / Applied — Third extension granted (statement of use) (as of 28 Jan 2026)
What this means for you
Not registered yet, but its 27 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97813070
- Mark type
- Stylized text
- Filed
- 27 Feb 2023
- Published for opposition
- 11 Jun 2024
- Attorney of record
- Brent R. Bellows
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceutical preparations that bind to asialoglycoprotein receptors; Research and development in the field of pharmaceuticals targeting diseases mediated by extracellular proteins; Pharmaceutical research and development
Owner
- Avilar Therapeutics, Inc., Waltham, MA, US
- Avilar Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 29 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jan 2026 — SOU EXTENSION 3 GRANTED
- 28 Jan 2026 — SOU EXTENSION 3 FILED
- 28 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Aug 2025 — SOU EXTENSION 2 GRANTED
- 04 Aug 2025 — SOU EXTENSION 2 FILED
- 04 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2024 — SOU EXTENSION 1 GRANTED
- 05 Dec 2024 — SOU EXTENSION 1 FILED
- 05 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jun 2024 — PUBLISHED FOR OPPOSITION